Dyphylline/Rutin/Acenocoumarol

二羟丙茶碱/芦丁/醋硝香豆素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDyphylline/Rutin/Acenocoumarol
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitorsVitamin K antagonists
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsIntracranial ArteriosclerosisCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes DyphyllineRutinAcenocoumarol
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsIntracranial ArteriosclerosisCerebrovascular Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A